Zobrazeno 1 - 10
of 81
pro vyhledávání: '"R (SABLICH"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Fabiana Zingone, R. Sablich, Linda Cingolani, Francesco Costa, Lorenzo Bertani, Davide Massimi, Cristina Canova, Edoardo Savarino, M.T. Urbano, Brigida Barberio, Giorgia Bodini, Piera Melatti, Andrea Buda, Giulia Barbieri, Maria Giulia Demarzo, Antonio Ferronato
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 14 (2021)
Therapeutic Advances in Gastroenterology
Therapeutic Advances in Gastroenterology
Background: Adalimumab is an effective and safe biological drug for the treatment of inflammatory bowel disease (IBD). Nowadays, several biosimilar agents are available, but data regarding their efficacy and safety in patients with IBD are still lack
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::766059a6676b8cbc9b433e092fea5ad6
http://hdl.handle.net/11577/3401606
http://hdl.handle.net/11577/3401606
Autor:
Fernando Rizzello, Antonio Ferronato, Luisa Moser, Stefano Festa, Chiara Ricci, Giorgia Bodini, Silvia Mazzuoli, Giuseppe Privitera, Francesca Rogai, R. Sablich, Angela Variola, Claudio Camillo Cortelezzi, Daniela Pugliese, Laurino Grossi, Maria Cappello, Lucrezia Laterza, Anna Viola, Maria Di Girolamo, Fabrizio Bossa, Giammarco Mocci, Antonino Carlo Privitera, Mariabeatrice Principi, Marco Daperno, Simone Saibeni, Rocco Spagnuolo, Mariangela Allocca, Greta Lorenzon, Sara Traini, Alessandro Armuzzi, G. Tapete, Filippo Mocciaro
Publikováno v:
United European Gastroenterology Journal
Background Few data exist regarding the long‐term effectiveness of golimumab in ulcerative colitis. No data have been reported on real‐world continuous clinical response. Objective This study aimed to describe the long‐term outcomes in a large
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9197205f9621fb7f1e53776980cdf1e3
https://hdl.handle.net/11585/796180
https://hdl.handle.net/11585/796180
Publikováno v:
Journal of Crohn's and Colitis. 16:i289-i289
Background In recent decades, biological drugs targeting anti-tumour necrosis factor-α (TNF-α) have represented the cornerstone in the treatment of inflammatory bowel diseases. Currently, anti- TNF-α represents a breakthrough in patient care. Howe
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Digestive and Liver Disease. 53:S167
Autor:
R. Sablich, G. Artico, P. Brosolo, A. Paviotti, D. Pozzetto, A.M. Baragiotta, L.B. Punturieri, G. Benevento, G. Zanette, M.T. Urbano, R. Cappiello
Publikováno v:
Digestive and Liver Disease. 52:S119-S120
Autor:
M T Urbano, Edoardo Savarino, A Ferronato, R Sablich, Renata D'Incà, A. Gubbiotti, Fabiana Zingone, Lorenzo Bertani, Brigida Barberio
Publikováno v:
Journal of Crohn's and Colitis. 14:S379-S379
Background There are limited real-life studies in medical literature evaluating the efficacy and safety of Ustekinumab, an Anti-IL-23/Anti IL-12 agent, in patients with Crohn’s disease (CD) who required treatment because of refractoriness or intole
Publikováno v:
Journal of Neurodevelopmental Disorders
Background Atypical sensory processing is a common clinical observation in autism spectrum disorder (ASD). Neural hyperexcitability has been suggested as the cause for sensory hypersensitivity, a frequently reported clinical observation in ASD. We ex
Autor:
Stefano Festa, Angela Variola, Antonio Ferronato, Claudio Ricci, Mariabeatrice Principi, A.C. Privitera, R. Sablich, Luisa Moser, G. Tapete, Giorgia Bodini, Maria Cappello, B. Orlandini, Giuseppe Costantino, Rocco Spagnuolo, Anna Viola, Francesca Rogai, Giammarco Mocci, Mariangela Allocca, Fabrizio Bossa, Greta Lorenzon, A. Armuzzi, F. Mocciaro, M. Di Girolamo, Claudio Camillo Cortelezzi, E. Capoferro, Silvia Mazzuoli, Daniela Pugliese, Laurino Grossi, Simone Saibeni
Publikováno v:
Digestive and Liver Disease. 50:e136